Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ironwood Pharmaceuticals, Inc.    IRWD

Delayed Quote. Delayed  - 07/27 09:05:34 pm
14.48 USD   +2.33%
07/21 IRONWOOD PHARMA : to Host Second Quarter 2016 Investor Update Call
07/15 Herbalife and Ironwood advance; Infosys and Fairmount drop
06/09 IRONWOOD PHARMA : and Allergan Announce Supplemental New Drug Applic..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector news 
Most relevant news about IRONWOOD PHARMACEUTICALS,
07/21 IRONWOOD PHARMACEUTICALS : to Host Second Quarter 2016 Investor Update Call
07/15 Herbalife and Ironwood advance; Infosys and Fairmount drop
06/09 IRONWOOD PHARMACEUTICALS : and Allergan Announce Supplemental New Drug Applicati..
06/06 IRONWOOD PHARMACEUTICALS : to Present at Jefferies 2016 Healthcare Conference
06/03DJASTRAZENECA : Completes US Licensing Pact with Ironwood Pharmaceuticals
06/03 IRONWOOD PHARMACEUTICALS : Closes U.S. Transaction with AstraZeneca for Lesinura..
06/01 IRONWOOD PHARMACEUTICALS : to Present at Goldman Sachs 37th Annual Global Health..
05/18 IRONWOOD PHARMACEUTICALS : to Present at 2016 UBS Global Healthcare Conference
05/17 IRONWOOD PHARMACEUTICALS : to Present Linaclotide Data at Digestive Disease Week..
05/17 IRONWOOD PHARMACEUTICALS : to Present Linaclotide Data at Digestive Disease Week..
05/09 IRONWOOD PHARMACEUTICALS : reports 1Q loss
05/09 IRONWOOD PHARMACEUTICALS : Provides First Quarter 2016 Investor Update
05/03 IRONWOOD PHARMACEUTICALS : to Present at Bank of America Merrill Lynch 2016 Heal..
05/03 INVESTOR INVESTIGATION OF IRONWOOD P : IRWD) Concerning Potential Violations of ..
04/28 Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Ironwood Pharma..
More most relevant news
All news about IRONWOOD PHARMACEUTICALS,
07/21 IRONWOOD PHARMACEUTICALS : to Host Second Quarter 2016 Investor Update Call
07/15 Herbalife and Ironwood advance; Infosys and Fairmount drop
06/16 IRONWOOD PHARMACEUTICALS : and Allergan Announce Supplemental New Drug Applicati..
06/16 IRONWOOD PHARMACEUTICALS : to Present at Jefferies 2016 Healthcare Conference
06/09 IRONWOOD PHARMACEUTICALS : to Present at Goldman Sachs 37th Annual Global Health..
06/09 IRONWOOD PHARMACEUTICALS : Closes U.S. Transaction with AstraZeneca for Lesinura..
06/09 IRONWOOD PHARMACEUTICALS : and Allergan Announce Supplemental New Drug Applicati..
06/06 IRONWOOD PHARMACEUTICALS : to Present at Jefferies 2016 Healthcare Conference
06/03 IRONWOOD PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Asset..
06/03 IRONWOOD PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holde..
More news
Sector news : Biotechnology & Medical Research - NEC
01:22p GSK chases next biotech asthma drug with 175 million pounds J&J deal
07/26 GILEAD SCIENCES : cuts 2016 sales forecast, cites hepatitis C drugs
07/25DJGILEAD SCIENCES : Sales of Hepatitis C Drugs Fall 19% -- 2nd Update
07/25DJCELGENE : Drug Misses Secondary Endpoint in One of Its Lymphoma Trials
07/25DJGILEAD SCIENCES : Sales of Hepatitis C Drugs Fall 19% -- 3rd Update
07/25DJGILEAD SCIENCES : Sales of Hepatitis C Drugs Fall 19% -- Update
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
07/25 European Ad Comm backs Allergan's Truberzi for IBS-D
07/22 What To Do With Your Relypsa Winnings
07/03 3 Plausible Buyout Scenarios Within Biotech
06/14 WHY RELYPSA IS LIKELY A ZERO : The Chronic Hyperkalemia Treatment Market Is Smal..
06/09 Application for lower dose constipation med Linzess under FDA review, decisio..
06/03 BIOTECHNOLOGY : Ready To Move Higher - Much Higher


Advertisement
Financials ($)
Sales 2016 250 M
EBIT 2016 -46,2 M
Net income 2016 -78,7 M
Debt 2016 110 M
Yield 2016 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales 2016 8,62x
EV / Sales 2017 6,45x
Capitalization 2 046 M
More Financials
Chart IRONWOOD PHARMACEUTICALS,
Duration : Period :
Ironwood Pharmaceuticals,  Technical Analysis Chart | IRWD | US46333X1081 | 4-Traders
Full-screen chart
Technical analysis trends IRONWOOD PHARMACE...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Average target price 13,6 $
Spread / Average Target -3,7%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Peter M. Hecht Chief Executive Officer & Director
Terrance G. McGuire Chairman
Thomas Graney Chief Financial Officer & SVP-Corporate Strategy
Mark G. Currie Chief Scientific Officer & Senior Vice President
Brian M. Cali Senior VP-Preclinical, Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
IRONWOOD PHARMACEUTICA..22.09%2 046
INCYTE CORPORATION-19.82%16 315
CELLTRION, INC.--.--%10 696
LONZA GROUP AG11.40%9 743
QUINTILES TRANSNATIONA..9.89%9 029
ALKERMES PLC-35.74%7 711
More Results